Lasse D. Jensen

Papers

Total Citations

H-Index

About

Lasse D. Jensen is a pioneering researcher at the forefront of cancer biology and biomedical engineering, whose work centers on developing and refining zebrafish xenograft models for personalized medicine. His major contributions lie in automating the labor-intensive microinjection process required for these models, a critical bottleneck in translating them from research tools to clinical diagnostics. By engineering automated systems, Jensen has dramatically improved the precision, throughput, and reproducibility of injecting cancer cells into fragile zebrafish larvae, enabling more reliable predictions of patient responses to therapeutics. His most-cited papers, including a 2025 publication with 5 citations and a 2024 work with 2 citations, underscore the growing recognition of his innovations. Notably, his research bridges the gap between preclinical models and real-world clinical application, positioning zebrafish xenografts as potential diagnostic tools for tailoring cancer treatments. Jensen’s work is not only technically groundbreaking but also holds profound implications for reducing the labor and expertise barriers in high-throughput drug screening, making him a key figure in advancing translational oncology.